DVAX Dynavax Technologies Corporation

-0.12  -1%
Previous Close 10.59
Open 10.66
Price To Book 6.75
Market Cap 656379775
Shares 62,691,478
Volume 1,063,634
Short Ratio
Av. Daily Volume 965,475

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 1/2 update at ESMO 2018 noted ORR 70%.
SD-101 + Pembrolizumab
Melanoma and head and neck squamous cell carcinoma (HNSCC)
CRL February 25, 2013 and November 14, 2016. Advisory Committee Meeting July 28, 2017 voted 21 -1 in favor of recommending approval. Final approval announced November 9, 2017.
Hepatitis B
Phase 2a trial did not meet primary endpoint - November 29, 2018.
Phase 1 safety and biomarker data due 1Q 2019 estimate.
Non-small Cell Lung Cancer (NSCLC)

Latest News

  1. Dynavax Technologies to Report Fourth Quarter and Full Year 2018 Financial Results and Host Conference Call on February 26
  2. Recent Analysis Shows Corcept Therapeutics, CDK Global, Dynavax Technologies, ICU Medical, American Vanguard, and Cabot Market Influences — Renewed Outlook, Key Drivers of Growth
  3. Why Dynavax Technologies Stock Marched Higher in January
  4. Heather Rowe Named Dynavax’s Vice President of Investor Relations and Corporate Communications
  5. Today's Research Reports on Trending Tickers: Dynavax Technologies and Tyme Technologies
  6. Why Dynavax Technologies Stock Fell 51% in 2018
  7. Is Dynavax Technologies Corporation (NASDAQ:DVAX) Worth US$10.80 Based On Intrinsic Value?
  8. 2 Small-Caps That Should Continue to Stage Comebacks in 2019
  9. Sam’s Club and Dynavax Technologies Corporation Announce Collaboration to Make HEPLISAV-B® Available to Sam’s Club Patients
  10. Here's Why Dynavax Technologies Slid 19% in December
  11. Dynavax to Present at 37th Annual J.P. Morgan Healthcare Conference
  12. The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials
  13. Edited Transcript of DVAX earnings conference call or presentation 5-Nov-18 9:30pm GMT
  14. Is Dynavax Technologies Corporation (DVAX) Going to Burn These Hedge Funds?
  15. Why Dynavax Technologies Corporation Fell 20.2% in October
  16. Dynavax Technologies: 3Q Earnings Snapshot
  17. Don't Waste Your Money on Penny Stocks; These 3 Stocks Are Better Buys